title: Effects of CAPD on hepatosteatosis and lipid profile.
authors.forename: Hayriye
authors.initials: H
authors.lastname: Sayarlioglu
authors.forename: Reha
authors.initials: R
authors.lastname: Erkoc
authors.forename: Omer
authors.initials: O
authors.lastname: Etlik
authors.forename: Mehmet
authors.initials: M
authors.lastname: Sayarlioglu
authors.forename: Ekrem
authors.initials: E
authors.lastname: Dogan
authors.forename: Pinar
authors.initials: P
authors.lastname: Kara
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood*; D005234:Fatty Liver / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D014280:Triglycerides / Q000097:blood*
chemical_list: D014280:Triglycerides; D002784:Cholesterol